Cargando…
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations
Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants con...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290254/ https://www.ncbi.nlm.nih.gov/pubmed/32577215 http://dx.doi.org/10.1177/2045125320933404 |
_version_ | 1783545633021362176 |
---|---|
author | Scholten, Willemijn Batelaan, Neeltje Van Balkom, Anton |
author_facet | Scholten, Willemijn Batelaan, Neeltje Van Balkom, Anton |
author_sort | Scholten, Willemijn |
collection | PubMed |
description | Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants contribute to unnecessary or undesirable long-term use. Identifying barriers prior to, during and following discontinuation may enable strategies to overcome them. This narrative review summarises relevant qualitative and quantitative articles on perceived barriers to discontinuing antidepressants and provides recommendations for clinical practice. We can conclude that implications for clinical practice are diverse and the most important barriers experienced by patients and physicians include the fear of relapse or recurrence, insufficient evaluation and monitoring, withdrawal symptoms, and actual relapse or recurrence. |
format | Online Article Text |
id | pubmed-7290254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72902542020-06-22 Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations Scholten, Willemijn Batelaan, Neeltje Van Balkom, Anton Ther Adv Psychopharmacol Discontinuing Psychotropic Medications Use of antidepressants has recently increased, mainly caused by the increase of long-term users. Although evidence-based indications for long-term use are lacking, it is assumed that long-term use is unnecessary or undesirable in some patients. Perceived barriers to discontinuing antidepressants contribute to unnecessary or undesirable long-term use. Identifying barriers prior to, during and following discontinuation may enable strategies to overcome them. This narrative review summarises relevant qualitative and quantitative articles on perceived barriers to discontinuing antidepressants and provides recommendations for clinical practice. We can conclude that implications for clinical practice are diverse and the most important barriers experienced by patients and physicians include the fear of relapse or recurrence, insufficient evaluation and monitoring, withdrawal symptoms, and actual relapse or recurrence. SAGE Publications 2020-06-10 /pmc/articles/PMC7290254/ /pubmed/32577215 http://dx.doi.org/10.1177/2045125320933404 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Discontinuing Psychotropic Medications Scholten, Willemijn Batelaan, Neeltje Van Balkom, Anton Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title | Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title_full | Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title_fullStr | Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title_full_unstemmed | Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title_short | Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
title_sort | barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations |
topic | Discontinuing Psychotropic Medications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290254/ https://www.ncbi.nlm.nih.gov/pubmed/32577215 http://dx.doi.org/10.1177/2045125320933404 |
work_keys_str_mv | AT scholtenwillemijn barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations AT batelaanneeltje barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations AT vanbalkomanton barrierstodiscontinuingantidepressantsinpatientswithdepressiveandanxietydisordersareviewoftheliteratureandclinicalrecommendations |